Wells Fargo & Company Amarin Corp Plcuk Transaction History

Wells Fargo & Company

$429 Billion
Q1 2025

A detailed history of Wells Fargo & Company transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Wells Fargo & Company holds 51,667 shares of AMRN stock, worth $864,388. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,667

Previous 49,667 4.03%

Holding current value

$864,388

Previous $23,000 1908.7%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$0.4 - $8.96 $800 - $17,920	2,000 Added 4.03%	51,667 $462,000
Q4 2024 Feb 12, 2025	SELL	$0.44 - $0.63 $1,100 - $1,575	-2,500 Reduced 4.79%	49,667 $23,000
Q3 2024 Nov 13, 2024	SELL	$0.57 - $0.8 $15,256 - $21,412	-26,766 Reduced 33.91%	52,167 $32,000
Q2 2024 Aug 13, 2024	BUY	$0.63 - $1.07 $16,233 - $27,570	25,767 Added 48.47%	78,933 $54,000
Q1 2024 May 10, 2024	SELL	$0.82 - $1.35 $1,836 - $3,024	-2,240 Reduced 4.04%	53,166 $47,000
Q4 2023 Feb 09, 2024	SELL	$0.66 - $0.91 $15,345 - $21,157	-23,250 Reduced 29.56%	55,406 $48,000
Q3 2023 Nov 13, 2023	BUY	$0.85 - $1.43 $4,291 - $7,220	5,049 Added 6.86%	78,656 $72,000
Q2 2023 Aug 15, 2023	SELL	$1.12 - $1.49 $28,809 - $38,327	-25,723 Reduced 25.9%	73,607 $87,000
Q1 2023 May 12, 2023	SELL	$1.19 - $2.19 $5,071 - $9,333	-4,262 Reduced 4.11%	99,330 $148,000
Q4 2022 Feb 13, 2023	SELL	$1.07 - $1.34 $32,576 - $40,796	-30,445 Reduced 22.71%	103,592 $125,000
Q3 2022 Nov 14, 2022	SELL	$1.09 - $1.67 $15,129 - $23,179	-13,880 Reduced 9.38%	134,037 $146,000
Q2 2022 Aug 12, 2022	SELL	$1.13 - $3.69 $36,999 - $120,821	-32,743 Reduced 18.12%	147,917 $220,000
Q1 2022 May 16, 2022	BUY	$2.85 - $3.73 $29,526 - $38,642	10,360 Added 6.08%	180,660 $595,000
Q4 2021 Feb 14, 2022	SELL	$3.24 - $5.18 $79,311 - $126,801	-24,479 Reduced 12.57%	170,300 $574,000
Q3 2021 Nov 15, 2021	SELL	$3.94 - $5.84 $237,463 - $351,976	-60,270 Reduced 23.63%	194,779 $994,000
Q2 2021 Aug 16, 2021	SELL	$4.26 - $6.5 $16,498 - $25,174	-3,873 Reduced 1.5%	255,049 $1.12 Million
Q1 2021 May 13, 2021	SELL	$5.03 - $8.8 $171,452 - $299,956	-34,086 Reduced 11.63%	258,922 $1.61 Million
Q4 2020 Feb 09, 2021	BUY	$4.04 - $5.31 $277,527 - $364,770	68,695 Added 30.62%	293,008 $1.43 Million
Q3 2020 Nov 05, 2020	BUY	$3.64 - $7.76 $140,733 - $300,024	38,663 Added 20.83%	224,313 $945,000
Q2 2020 Aug 13, 2020	BUY	$4.78 - $8.26 $131,540 - $227,306	27,519 Added 17.4%	185,650 $1.29 Million
Q1 2020 May 14, 2020	BUY	$4.0 - $21.53 $632,524 - $3.4 Million	158,131 New	158,131 $632,000

Others Institutions Holding AMRN

# of Institutions

154

Shares Held

70.1M

Call Options Held

133K

Put Options Held

26.4K

View Full List

About AMARIN CORP PLCUK

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $6.75B
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

More about AMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Amarin Corp Plcuk Transaction History